A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient
- PMID: 34587536
- PMCID: PMC8467371
- DOI: 10.1016/j.ijid.2021.09.055
A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient
Abstract
We report a case of varicella zoster virus (VZV) meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient. A final diagnosis was made based on identification of VZV via positive polymerase chain reaction of cerebrospinal fluid along with characteristic symptoms such as fever, headache, and stiff neck. This phenomenon has been reported elsewhere; this is the 13th such case reported worldwide and the 7th case in immunocompetent patients, indicating the need for careful monitoring after COVID-19 vaccines.
Keywords: BNT162b2 mRNA COVID-19 vaccination; COVID-19; SARS-CoV-2; Varicella zoster virus.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflict of interest The authors state that they have no conflict of interest.
Figures
References
-
- Bostan E, Yalici-Armagan B. Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence? J Cosmet Dermatol. 2021;20:1566–1567. - PubMed
-
- Ministry of Health, Labour and Welfare, Japan. Report of suspected adverse reactions of COVID-19 vaccine [cited 2021 Jun 23]. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_hukuhannou-utag...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
